PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,294 | -1.9% | 3,468 | 0.0% | 0.00% | – |
| Q2 2023 | $21,710 | +2.5% | 3,468 | -21.9% | 0.00% | – |
| Q1 2023 | $21,178 | -71.3% | 4,440 | -47.6% | 0.00% | – |
| Q4 2022 | $73,785 | -26.9% | 8,481 | 0.0% | 0.00% | – |
| Q3 2022 | $101,000 | -12.9% | 8,481 | +4.4% | 0.00% | – |
| Q2 2022 | $116,000 | -21.1% | 8,122 | +14.9% | 0.00% | – |
| Q1 2022 | $147,000 | -10.4% | 7,067 | -0.1% | 0.00% | – |
| Q4 2021 | $164,000 | -21.5% | 7,076 | +0.9% | 0.00% | – |
| Q3 2021 | $209,000 | +95.3% | 7,016 | +124.4% | 0.00% | – |
| Q2 2021 | $107,000 | +127.7% | 3,126 | +118.8% | 0.00% | – |
| Q1 2021 | $47,000 | -47.8% | 1,429 | -3.1% | 0.00% | – |
| Q4 2020 | $90,000 | -94.8% | 1,474 | -96.8% | 0.00% | -100.0% |
| Q3 2020 | $1,730,000 | – | 46,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |